Profilo
Dr. Michael Häggman is an Independent Director at Prostatype Genomics AB, an Associate Professor-Urology at Uppsala University Hospital, a Deputy Director at Kardinaltalet AB and a General Partner at Skrotum Kommanditbolag.
He is on the Board of Directors at Prostatype Genomics AB and Chundsell Medicals AB.
Posizioni attive di Michael Häggman
| Società | Posizione | Inizio |
|---|---|---|
| PROSTATYPE GENOMICS AB | Direttore/Membro del Consiglio | 01/01/2018 |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Direttore/Membro del Consiglio | - |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Corporate Officer/Principal | - |
Skrotum Kommanditbolag | Corporate Officer/Principal | - |
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Health Services |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Health Technology |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Prostatype Genomics AB
Prostatype Genomics AB Medical SpecialtiesHealth Technology Develops, manufactures and markets prognostic genetic test prostatype equipment | Health Technology |
Skrotum Kommanditbolag |
















